THE EARLY INTRODUCTION OF HMG-COA REDUCTASE INHIBITORS COULD PREVENT THE INCIDENCE OF TRANSPLANT CORONARY ARTERY DISEASE.

1999 ◽  
Vol 67 (7) ◽  
pp. S38
Author(s):  
Tomoko Kato ◽  
Nadia Giannetti ◽  
Shao-Zhou Gao ◽  
Sharon A. Hunt
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Hmg Coa Reductase ◽  
Early Introduction ◽  
Reductase Inhibitors ◽  
Hmg Coa Reductase Inhibitors ◽  
Artery Disease ◽  
Coa Reductase

HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease

1999 ◽  
Vol 147 (2) ◽  
pp. 237-242 ◽  
Author(s):  
Mikko J Järvisalo ◽  
Jyri O Toikka ◽  
Tommi Vasankari ◽  
Jorma Mikkola ◽  
Jorma S.A Viikari ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Endothelial Function ◽  
Hmg Coa Reductase ◽  
Reductase Inhibitors ◽  
Hmg Coa Reductase Inhibitors ◽  
Artery Disease ◽  
Coa Reductase

scholarly journals Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors

Circulation ◽  
2004 ◽  
Vol 109 (16) ◽  
pp. 1966-1972 ◽  
Author(s):  
Torgun Wæhre ◽  
Arne Yndestad ◽  
Camilla Smith ◽  
Terje Haug ◽  
Siv Haugen Tunheim ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Interleukin 1 ◽  
Hmg Coa Reductase ◽  
Reductase Inhibitors ◽  
Hmg Coa Reductase Inhibitors ◽  
Artery Disease ◽  
Coa Reductase
Sign in / Sign up

Export Citation Format

Share Document